FBL and hepatocellular carcinoma: The remaining 48 HCC patients (28% of all HCC patients and 2% of the overall cohort) developed HCC without ever passing through the stage of liver cirrhosis as defined by the Fib-4 threshold of >3.25 (Table 2; Fig. 1).